Typical timeline
6–18 months
Timeline depends heavily on existing facility maturity and which market's GMP framework applies.
Manufacturing Quality
Good Manufacturing Practice (GMP)
The manufacturing quality framework underlying most device and pharmaceutical regulatory approvals worldwide.
Overview
What GMP is and why it matters
Good Manufacturing Practice (GMP) refers to the systems and procedures ensuring products are consistently produced and controlled to quality standards. GMP requirements are embedded within most national device and pharmaceutical regulatory frameworks (FDA's Quality System Regulation, EU GMP, WHO GMP, Brazil's BGMP) rather than existing as one single global certificate.
Requirements
What you'll need
The documentation and evidence a complete submission is normally built from.
- Facility and equipment qualification
- Documented manufacturing procedures and batch records
- Personnel training and hygiene controls
- Quality control testing and product release procedures
- Change control and deviation management
- Periodic regulatory inspections
Planning ranges
Typical timeline and estimated cost
Ranges illustrate general market patterns for this pathway — they are not a quote for a specific product.
Estimated cost
$20k–$200k
Facility upgrades to meet GMP standards, where needed, can be the single largest cost item in a market-entry budget.
Timelines and costs above are typical ranges illustrating general market patterns, not a quote or regulatory conclusion for your specific product. Actual figures depend on device classification, target country, and applicant readiness — professional review is required before relying on this for a business decision.
Where this applies
Applicable countries
Jurisdictions that recognise this certification. Scope and conditions still vary by product classification.
Global — requirements are market-specific
Related
Regulatory Pathways
FAQ
Frequently asked questions
Is GMP the same everywhere?
No — GMP is a set of principles implemented differently by each regulator (FDA, EU, WHO, and country-specific authorities like Brazil's ANVISA each maintain their own GMP framework and inspection regime).
Reviewed packages
Buy a defined outcome
Pay for a market-access outcome — not a feature tour
Market Entry Sprint from $2,500 · Strategy Session $500 · Pathway Brief $1,800. Professional review required before business use. No patient data on public forms.
Reviewed launch planning
Need a GMP pathway brief?
GMP pathway briefs start at $1,800. Or book a $2,500 Market Entry Sprint that includes regulatory pathway outline, evidence flags, and a review call.
Professional review is required before business use.